Latest Kaiser Health News Stories
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
In September, the Trump administration announced its plan to end the Deferred Action for Childhood Arrivals program, setting off an ongoing political and legal battle that could doom the dreams of immigrant doctors in training.
The deadly storm turned a health challenge into a full-blown medical crisis for one young man with unconfirmed multiple sclerosis. And still he waits to see a neurologist.
Though opioid prescriptions appear to be on the decline, Vicodin and Norco remain popular, especially in the South. In more than half of states, Synthroid — a drug to treat hypothyroidism — came in at No. 1.
Health care tech startup Theranos was riding high back in 2014. But when a reporter raised questions, its media reps circled the wagons.
Federal health officials recommend that adults get a number of vaccinations, including protections against shingles, the flu, pneumonia, tetanus, diphtheria and pertussis. But immunization rates are generally low.
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
The state’s ambitious payment overhaul has begun to demonstrate savings and a change in culture, say new reports.
How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
Last month’s budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.
Researchers at the University of Southern California analyzed millions of prescriptions and concluded that close to a quarter paid copays that exceeded the cost of the drugs.
Starting this spring, aspiring doctors at the Oregon Health & Science University must prove they can communicate about difficult subjects ranging from admitting medical mistakes to notifying families about a patient’s death.
The federal Centers for Medicare & Medicaid Services advised the state that its plan to offer state-based insurance plans falls short of the Obamacare rules and could result in penalties for insurers.
KHN correspondent Shefali Luthra answered a wide variety of questions about health care in a Reddit “Ask Me Anything” chat.
Begun as a health care safety net for children and low-income families, Medicaid increasingly underwrites a range of services in America’s public schools.
As states brace for insurance market instability, some — like Maryland — take aggressive action.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and new podcast panelist Anna Edney of Bloomberg News discuss this week’s spate of speeches by the leaders of the Department of Health and Human Services. They also discuss the slow progress on health legislation on Capitol Hill intended to fund the government and stabilize the individual insurance market. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Public health agencies are set up to regulate easily controlled sources of air pollution. Wildfire smoke presents a different set of expensive challenges.